Maintaining Your Momentum Understanding the shelf life of your treatment is a small but vital part of the bigger picture
This study can help to inform patient care and outcomes today, not months from now. This story has been updated with a statement from Novo Nordisk as well as additional context about the analysis.
Metabolic rewiring of bacterial pathogens in response to antibiotic pressurea molecular perspective
It is sometimes formulated with a drug affinity complex (DAC) to extend its half-life in the body
announced it would discontinue developing danuglipron, an oral GLP-1 receptor agonist for chronic weight management
According to the SmPC, nausea is very common (affecting approximately 44% of patients), while vomiting, diarrhoea, constipation, and abdominal pain are common side effects